Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epoprostenol | 3 | 2004 | 45 | 0.300 |
Why?
|
| Fallopian Tubes | 3 | 2004 | 77 | 0.290 |
Why?
|
| Muscle Contraction | 2 | 2002 | 154 | 0.230 |
Why?
|
| Muscle, Smooth | 2 | 2002 | 130 | 0.200 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2022 | 764 | 0.130 |
Why?
|
| Uterine Rupture | 1 | 1996 | 18 | 0.120 |
Why?
|
| Embryo Transfer | 1 | 1996 | 58 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 1018 | 0.120 |
Why?
|
| Fertilization in Vitro | 1 | 1996 | 163 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 3 | 2004 | 41 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2004 | 115 | 0.110 |
Why?
|
| Ribosomal Proteins | 1 | 2011 | 73 | 0.090 |
Why?
|
| Cerebellar Ataxia | 1 | 2011 | 69 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 774 | 0.060 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 66 | 0.060 |
Why?
|
| Pelvic Neoplasms | 1 | 2003 | 24 | 0.050 |
Why?
|
| Prostaglandins H | 1 | 2002 | 3 | 0.050 |
Why?
|
| Prostaglandin H2 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Iloprost | 1 | 2002 | 8 | 0.050 |
Why?
|
| Receptors, Epoprostenol | 1 | 2002 | 7 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 1 | 2002 | 14 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2003 | 46 | 0.050 |
Why?
|
| Tritium | 1 | 2002 | 117 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2004 | 221 | 0.050 |
Why?
|
| Adenylyl Cyclases | 1 | 2002 | 67 | 0.050 |
Why?
|
| Scalp | 1 | 2022 | 57 | 0.050 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2022 | 119 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2002 | 234 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 222 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2002 | 1085 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 1292 | 0.040 |
Why?
|
| Binding Sites | 1 | 2002 | 1253 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2002 | 3062 | 0.030 |
Why?
|
| Pregnancy, Ectopic | 1 | 1996 | 23 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 2 | 2004 | 27 | 0.030 |
Why?
|
| Nitrobenzenes | 2 | 2004 | 15 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2004 | 53 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2004 | 48 | 0.030 |
Why?
|
| Female | 6 | 2022 | 70788 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 2 | 2004 | 127 | 0.030 |
Why?
|
| Mutagenicity Tests | 1 | 2011 | 20 | 0.020 |
Why?
|
| Sulfonamides | 2 | 2004 | 282 | 0.020 |
Why?
|
| Hyperpigmentation | 1 | 2011 | 13 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 378 | 0.020 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 270 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2011 | 227 | 0.020 |
Why?
|
| Pregnancy | 2 | 2004 | 7567 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 634 | 0.020 |
Why?
|
| Anemia | 1 | 2011 | 351 | 0.020 |
Why?
|
| Humans | 5 | 2022 | 132336 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1005 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 554 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2004 | 1598 | 0.020 |
Why?
|
| Middle Aged | 2 | 2022 | 28888 | 0.010 |
Why?
|
| Eicosanoids | 1 | 2004 | 13 | 0.010 |
Why?
|
| Blastocyst | 1 | 2004 | 79 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 309 | 0.010 |
Why?
|
| Microsomes | 1 | 2002 | 40 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2002 | 70 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 4767 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 4545 | 0.010 |
Why?
|
| Mice | 2 | 2011 | 18571 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 4695 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 4725 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 1723 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 903 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1964 | 0.010 |
Why?
|
| Animals | 2 | 2011 | 34989 | 0.010 |
Why?
|
| Male | 1 | 2022 | 65054 | 0.010 |
Why?
|
| Adult | 1 | 1996 | 31618 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 3853 | 0.010 |
Why?
|